In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the impact of an anti-CD3 monoclonal antibody (mAb) called Foralumab in coronavirus disease ...

Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

Newswise - San Francisco, CA. (August 22, 2011) - A simple new approach to nasal drug administration may allow morphine and other strong pain medications to be targeted directly to the central nervous ...

Recent advances in drug delivery have led to significant innovations including polymer implants, transdermal patches, and sophisticated oral controlled-release formulations. These technologies, ...

A recent study published in Pathogens reported that an intranasal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine induced mucosal immune responses in mice. Study: Intranasal ...

Transmucosal administration of medications is not a unique concept to the healthcare system. Medications delivered by such a means include fentanyl transmucosal lozenges, sublingual nitroglycerin, and ...

Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposure FDA denial of Sanofi’s ...

Etripamil is a self-administered nasal spray designed to be a rapid-response therapy for episodic cardiovascular conditions. Positive topline data were announced from a phase 3 trial evaluating the ...

The ReBoost Nasal Spray may contain mold and microbial contamination, while the ClearLife Allergy Nasal Spray may be linked to the same bacteria.